SCHEMBL29989656

SCHEMBL29989656

O=S(=O)(Cl)c1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 1/20 0.52
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CCR2 P41597 7/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
KDR P35968 1/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CNR2 P34972 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127681 1.00 MEP1B (0.52) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL6209362 0.86 MEP1B (0.54) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL1762329 0.85 CCR2 (0.44) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL1942107 0.85 HSD11B1 (0.40) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL6536620 0.84 KIF11 (0.42) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL2952580 0.83 CA2 (0.62) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL172392 0.83 CCR2 (0.58) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL10763658 0.83 MEP1B (0.55) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
Hydrochloric Acid SCHEMBL27767307 0.81 MEP1B (0.54) MEP1BTSHRSMN1; SMN2POLBL3MBTL1
SCHEMBL67150 0.81 CCR2 (0.45) CCR2LMNAMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117858879-A CDK2/4/6 inhibitor and preparation method and application thereof 南京再明医药有限公司 2024-04-09 CN disclosed
WO-2023031308-A1 CCR2 INHIBITORS ARTICA THERAPEUTICS B.V. (NL) 2023-03-09 WO disclosed
CN-115768750-A GCN2 modulator compounds 阿莱斯塔治疗公司 2023-03-07 CN disclosed
EP-4107146-A1 GCN2 MODULATOR COMPOUNDS Alesta Therapeutics BV (NL) 2022-12-28 EP disclosed
WO-2022234867-A1 SULFONAMIDE HAVING MMP 7-INHIBITING ACTION 大正製薬株式会社 2022-11-10 WO disclosed